CTRI/2015/07/005985已完成4 期
An observational, multi-center, open label study assessing the efficacy and safety of Lucentis (Ranibizumab intravitreal injections) in patients with visual impairment due to macular edema secondary to retinal vein occlusion (RVO)
ovartis Healthcare Pvt Ltd0 个研究点目标入组 100 人开始时间: 待定最近更新:
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •1. Patients willing to provide signed written informed consent.
- •2. Male and female aged 18 years and above.
- •3. Patients with macular edema due to BRVO and CRVO (confirmed by fundus photography, fluorescein angiography, OCT).
- •4. Baseline best-corrected visual acuity (BCVA) in the study eye from perception of light + (PL+) to 6/9 on Snellen chart
排除标准
- •1. Additional eye disease that could compromise VA
- •2. Active intraocular inflammation in either eye
- •3. Uncontrolled glaucoma in the study eye
- •4. Intraocular surgery <=1 month before day 0
- •5. Any contra-indication according to local Summary of Product Characteristics or Prescribing Information (SmPC or PI) of ranibizumab
研究者
相似试验
招募中
不适用
Multi-centered open-label, observational study of Sitagliptin in West Tokyo AreaType2 diabetesJPRN-UMIN000003362Tama-center Mirai Clinic100
已完成
4 期
A observational study to evaluate the efficacy and safety of Ranibizumab in patients with visual impairment due to Diabetic Macular Edema(DMECTRI/2015/06/005945ovartis Healthcare Pvt Ltd
进行中（未招募）
1 期
A study to evaluate the efficacy and safety of ibrutinib and ofatumumab in untreated patients with chronic lymphocytic leukemia or small cell lymphocytic lymphoma.EUCTR2016-004937-26-ESFundación PETHEMA
招募中
4 期
To find the effectiveness and safety of nefopam tablet in pain associated with trauma.CTRI/2019/06/019801Abbott India Ltd
招募中
不适用
The evaluation of the durability and efficacy of nateglinide therapy fro long term glycemic control compared with glimepiride in type 2 diabetic patientsKCT0000052Ajou University Hospital200